This review article explores the role of endogenous lipopolysaccharides (LPS)—toxic components from Gram-negative bacteria—in the development of neurological disorders. It explains how gut dysbiosis and increased intestinal permeability allow LPS to enter the bloodstream, triggering systemic inflammation, blood-brain barrier (BBB) disruption, and activation of microglia and astrocytes. These immune responses
